Gökhan Keser

ORCID: 0000-0003-2382-6027
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bacteriophages and microbial interactions
  • Monoclonal and Polyclonal Antibodies Research
  • Chalcogenide Semiconductor Thin Films
  • Pharmacological Effects of Natural Compounds
  • Microbial infections and disease research
  • Rheumatoid Arthritis Research and Therapies
  • Shoulder and Clavicle Injuries
  • Systemic Sclerosis and Related Diseases
  • Spinal Fractures and Fixation Techniques
  • Copper-based nanomaterials and applications
  • Bacillus and Francisella bacterial research
  • Infectious Diseases and Tuberculosis
  • Vasculitis and related conditions
  • Pregnancy and Medication Impact
  • Cardiovascular Issues in Pregnancy
  • Food Allergy and Anaphylaxis Research
  • Quantum Dots Synthesis And Properties
  • Spondyloarthritis Studies and Treatments
  • Drug-Induced Adverse Reactions

Ege University
2002-2024

Bursa Uludağ Üni̇versi̇tesi̇
2020

This study aimed to examine fetomaternal outcomes in pregnant women a large Turkish Takayasu arteritis (TAK) cohort and evaluate the effects of pregnancy on disease those patients.This is involving 296 pregnancies 112 TAK patients from 8 tertiary rheumatology centers Turkey. Pregnancies were divided into 2 groups as pre-d (before onset) post-d (after onset). In addition, further subgroups according complications (FMC) development status. Finally, grouped with without history after onset.In...

10.1111/1756-185x.14247 article EN International Journal of Rheumatic Diseases 2021-11-17

To evaluate the development of anti-drug antibodies (ADAb) against tumor necrosis factor inhibitors (TNFi) therapy during a 2-year period and search factors linked to patients with axial spondyloarthritis (axSpA).

10.5152/eurjrheum.2024.24013 article EN cc-by-nc European Journal of Rheumatology 2024-10-25

10.1007/s10854-020-04120-0 article EN Journal of Materials Science Materials in Electronics 2020-08-07

C›kar cak›flmas› / Conflicts of interest: bulunmad›¤› belirtilmifltir. No conflicts declared. www.raeddergisi.org doi:10.2399/raed.15.S1S8 Karekod QR code: Ulkemizde kullan›lmakta olan tumor nekrotizan faktor alfa inhibitoru (anti-TNF-α) ajanlar ailesine en son kat›lan ve grubun beflinci uyesi sertolizumab pegol (CZP), TNF-α’ya karfl› oluflturulmufl humanize bir monoklonal antikorun, rekombinan yap›da polietilen glikol ile pegilize edilmifl Fab k›sm›ndan oluflur. Bu yeni molekulu, tum di¤er...

10.2399/raed.15.s1s8 article TR RAED Dergisi 2015-09-01
Coming Soon ...